Search Results 1281-1290 of 19030 for Neutrophil

1. Testing the Addition of the Drug Atezolizumab to the Usual Radiation Treatment for Patients With Early Non-small Cell Lung Cancer - Mayo Clinic

   Patient must have absolute neutrophil count (ANC), platelets, and hemoglobin measured within 28 days prior to randomization. The purpose of these tests is ...

2. Study Of Targeted Therapy Vs. Chemotherapy In Patients With Thyroid Cancer - Mayo Clinic

   * Absolute neutrophil count (ANC) ≥ 1,500/mcL obtained ≤ 28 days prior to protocol randomization * Platelets ≥ 100,000/mcL obtained ≤ 28 days prior to ...

3. Radiation Therapy with Durvalumab or Cetuximab to Treat Patients with Locoregionally Advanced Head and Neck Cancer who Cannot Take Cisplatin - Mayo Clinic

   Absolute neutrophil count (ANC) ≥ 1,000 cells/mm^3 (within 14 days prior to step 1 registration);. Platelets ≥ 100,000 cells/mm^3 (within 14 days prior to ...

4. Sirolimus, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients At High Risk for Cholangiocarcinoma Recurrence After Liver Transplant or Surgery - Mayo Clinic

   Absolute neutrophil count (ANC) ≥ 1500/μL obtained ≤ 7 days prior to registration; Platelets (PLT) ≥ 100,000/μL obtained ≤ 7 days prior to registration ...

5. A Study to Compare Radiation Therapy + Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer - Mayo Clinic

   Absolute neutrophil count (ANC) ≥ 1,000/cells/mm^3 (within 14 days prior to registration). Platelets ≥ 75,000 cells/mm^3 (within 14 days prior to ...

6. A Study of Preventive Treatment of Oxaliplatin Induced Peripheral Neuropathy in Metastatic Colorectal Cancer (POLAR-M) - Mayo Clinic

   Adequate hematological parameters: hemoglobin ≥ 100 g/L, absolute neutrophil count (ANC) ≥ 1.5 x 10^9 /L, platelets ≥ 100 x 10^9 /L. Adequate renal ...

7. Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Patients With Metastatic Breast Cancer - Mayo Clinic

   ECOG performance status of 0 or 1. 6. Patient has adequate bone marrow and organ function, as defined by the following laboratory values: 1. Absolute neutrophil ...

8. Testing Proton Craniospinal Radiation Therapy Versus The Usual Radiation Therapy For Leptomeningeal Metastasis, RADIATE-LM Trial - Mayo Clinic

   * Absolute neutrophil count (ANC) ≥ 1,000/mm^3 (Note: the use of granulocyte-colony stimulating factor or other intervention to achieve ANC ≥ 1,000/mm^3 ...

9. A Study of Treatment with Docetaxel and Prednisone, with or without Vaccine Therapy, for Patients who have Metastatic Hormone-Resistant Prostate Cancer - Mayo Clinic

   Absolute neutrophil count (ANC) ≥ 1500/mm^3; Platelet count ≥ 100,000/mm^3; Creatinine ≤ 2.0 mg/dL; Aspartate aminotransferase (AST), alanine ...

10. Testing Whether Treating Breast Cancer Metastases With Surgery or High-Dose Radiation Improves Survival - Mayo Clinic

    Absolute neutrophil count (ANC) ≥ 500 cells/mm^3. Platelets ≥ 50,000 cells/mm^3. Hemoglobin ≥ 8.0 g/dl: The use of transfusion or other intervention to ...